{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"condition":["Colorectal Carcinoma","Colorectal Neoplasms"],"disease":["Colorectal Carcinoma","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2314733"],"location":["China"],"study_start_month":["10"],"keyword":["Adjuvant chemotherapy","Electronic patient reported outcomes"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma","description":"It is a multi-centric randomized controlled trial. The goal of this study is to observe the improvement of QoL using ePRO to manage patients with colorectal cancer who received Oxaliplatin-based adjuvant chemotherapy.The prognosis will also be studied.","dates":{"creation":"2019-10-15"},"accession":"2314733","cross_references":{"ClinicalTrials___gov":["NCT04069455"]}}